February 1, 2017 / 6:13 AM / a year ago

BRIEF-Sanofi and Regeneron announce first approval of Kevzara

PARIS, Feb 1 (Reuters) - Sanofi /Regeneron :

* Sanofi and Regeneron Pharmaceuticals, Inc. today announced that Health Canada approved Kevzara(TM)

* Product approved for treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more biologic or non-biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs)

Source text on Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below